Discover

JSPR
Jasper Therapeutics, Inc.
0.44
1 x 0.33
2 x 0.57
bid
ask
-
0.02
3.32%
01:08 PM
timesize
Ytd-75.99%
1y-93.56%
0.43
day range
0.48
0.32
52 week range
7.19
Open0.46Prev Close0.45Low0.43High0.48Mkt Cap12.17M
Vol160.87KAvg Vol539.30KEPS-2.58P/EN/AForward P/E-4.89
Beta2.20Short Ratio9.32Inst. Own100.34%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg0.72200-d Avg1.451yr Est68.78
Income Statement
Operating Expenses10.95M
Research and Development Expense5.81M
Selling, General and Administrative Expense5.14M
Operating Income-10.95M
Net Income-1.17M
Net Income Common Stock-1.17M
Net Income Common Stock (USD)-1.17M
Consolidated Income-1.17M
Earnings per Basic Share-0.04
Earnings per Basic Share (USD)-0.04
Earnings per Diluted Share-0.04
Earning Before Interest & Taxes (EBIT)-1.17M
Earning Before Interest & Taxes (USD)-1.17M
Weighted Average Shares28.67M
Weighted Average Shares Diluted28.67M
Balance Sheet
Cash and Equivalents14.56M
Cash and Equivalents (USD)14.56M
Current Assets20.29M
Property, Plant & Equipment Net398.00K
Total Assets21.18M
Debt Current757.00K
Total Debt757.00K
Current Liabilities9.00M
Total Liabilities17.78M
Accumulated Retained Earnings (Deficit)-317.84M
Shareholders Equity3.40M
Shareholders Equity (USD)3.40M
Assets Non-Current892.00K
Total Debt (USD)757.00K
Liabilities Non-Current8.79M
Trade and Non-Trade Payables2.44M
Cash Flow
Depreciation, Amortization & Accretion206.00K
Net Cash Flow / Change in Cash & Cash Equivalents-14.55M
Net Cash Flow from Operations-14.55M
Share Based Compensation423.00K